These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1248 related articles for article (PubMed ID: 26370157)
1. Fertility preservation options in breast cancer patients. Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157 [TBL] [Abstract][Full Text] [Related]
2. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER. Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337 [TBL] [Abstract][Full Text] [Related]
3. Fertility after breast cancer treatment. Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568 [TBL] [Abstract][Full Text] [Related]
4. Techniques for fertility preservation in patients with breast cancer. Dunn L; Fox KR Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489 [TBL] [Abstract][Full Text] [Related]
6. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
8. In vitro maturation of human immature oocytes for fertility preservation. Chian RC; Uzelac PS; Nargund G Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515 [TBL] [Abstract][Full Text] [Related]
9. Depot GnRH-agonist trigger for breast-cancer patient undergoing ovarian stimulation resulted in mature oocytes for cryopreservation: a case report. Cavagna M; Dzik A Reprod Biomed Online; 2011 Mar; 22(3):317-9. PubMed ID: 21273128 [TBL] [Abstract][Full Text] [Related]
10. New trends in female fertility preservation: in vitro maturation of oocytes. Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518 [TBL] [Abstract][Full Text] [Related]
11. [Breast cancer and fertility: critical review, considerations and perspectives]. This P Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566 [TBL] [Abstract][Full Text] [Related]
12. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617 [TBL] [Abstract][Full Text] [Related]
13. Strategies for fertility preservation in young early breast cancer patients. Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638 [TBL] [Abstract][Full Text] [Related]
14. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403 [TBL] [Abstract][Full Text] [Related]
15. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy]. Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272 [TBL] [Abstract][Full Text] [Related]
16. [Fertility preservation techniques in women of reproductive age ]. Vulliemoz N ; Gaitzsch H ; Primi M-P ; Wunder D ; Perey L ; Streuli I Rev Med Suisse; 2014 Oct; 10(447):1961-2, 1964-6, 1968. PubMed ID: 25518205 [TBL] [Abstract][Full Text] [Related]
17. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate. Fatum M; McVeigh E; Child T Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119 [TBL] [Abstract][Full Text] [Related]
18. [Oncofertility and breast cancer]. Sonigo C; Grynberg M; Bringer S; Sermondade N Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738 [TBL] [Abstract][Full Text] [Related]
19. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Elizur SE; Chian RC; Pineau CA; Son WY; Holzer HE; Huang JY; Gidoni Y; Levin D; Demirtas E; Tan SL Rheumatology (Oxford); 2008 Oct; 47(10):1506-9. PubMed ID: 18660508 [TBL] [Abstract][Full Text] [Related]
20. Fertility preservation in women with breast cancer. Rodriguez-Wallberg KA; Oktay K Clin Obstet Gynecol; 2010 Dec; 53(4):753-62. PubMed ID: 21048442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]